Acasti Pharma Inc

Research Acasti Pharma Inc (GRCE) on Bullrun: market cap USD 36.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGRCE
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 36.86M
• Financial periodFY2025
• Net income-USD 9.57M

Valuation Snapshot

latest market cap is USD 36.86M.

About Acasti Pharma Inc

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T);

Frequently asked questions

What is Acasti Pharma Inc's market cap?

Acasti Pharma Inc's market capitalization is USD 36.86M.

What does Acasti Pharma Inc do?

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage.